Neutropenia in Pediatric Oncological Patients

Carlos Rosales, Dulce Uribe Rosales, José de Jesús Ramos-Nieto, Eileen Uribe-Querol

Neutropenia - Facts and Understanding [Working Title](2024)

引用 0|浏览0
暂无评分
摘要
In 2020, more than 275,000 children and adolescents from 0 to 19 years of age were diagnosed with cancer in the world. Acute myeloid leukemia or acute lymphoblastic leukemia are the most frequent types of cancer. Leukemia is a serious condition that is fatal in many cases. Since tumor cells are present in both, bone marrow and circulating blood, very aggressive therapeutic treatments are required to eliminate tumor cells. Neutrophils are white blood cells that first respond against microbial pathogens and are produced in the bone marrow. Several drugs used in leukemia cancer treatment can reduce the total neutrophil number causing neutropenia. In this chapter we will briefly describe neutrophil maturation and functions as well as the different types of neutropenia. We will also focus on neutropenia consequences and some clinical approaches for treating neutropenia in pediatric patients.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要